You are admitted to hospital because of pulmonary embolism. You are treated with
anticoagulants.
The investigators know that, despite this treatment, pulmonary embolism can be a threat
especially if heart function is compromized.
The investigators investigate a well known study drug (epoprostenol) on top of regular
treatment with anticoagulants, to see if heart function can be optimized